Insmed (INSM) PT Raised to $92 at Mizuho, 'continue to favor it as our top longer-term idea'
Tweet Send to a Friend
Mizuho analyst Graig Suvannavejh raised the price target on Insmed (NASDAQ: INSM) to $92.00 (from $82.00) while maintaining a Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
